UBE2C and breast carcinoma: For example, overexpression of ubiquitin-conjugating enzyme E2C (UBE2C) has recently been thought to play a role in not only NSCLC, but also gastric, colorectal, and breast cancers (Wang et al., 2015; Pellino et al., 2016; Yang et al., 2016).